Self-renewing islet TCF1+ CD8 T cells undergo interleukin-27 controlled differentiation to become TCF1- terminal effectors during the progression of type 1 diabetes. Self-renewing islet TCF1+ CD8 T cells undergo interleukin-27 controlled differentiation to become TCF1- terminal effectors during the progression of type 1 diabetes
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
创建时间：
2020-08-03
